Sign In
test

David Kim

Paradigm Biocapital Advisors Lp

Assets Managed
$4.894B
Holdings
35
Last Quarter
2026 - Q1
Filed Date
12d ago
Growth Rate
24.93%(2Q avg: 18.18%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Paradigm Biocapital Advisors Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 35 positions.

Assets under management

The assets under management (AUM) of Paradigm Biocapital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 4.894B in assets, with a quarterly growth rate of 24.93% and a 2-quarter average growth rate of 18.18%. The portfolio is managed by David Kim, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
ACLX
Arcellx Inc
Recent Activity
Increased 0.88%
13.55%
$662.973M
5.774M shares@ $114.82 avg price
RVMD
Revolution Medicines Inc
Recent Activity
Increased 0.18%
13.23%
$647.267M
6.656M shares@ $97.26 avg price
NUVL
Nuvalent Inc-a
Recent Activity
Increased 1.05%
11.15%
$545.488M
5.324M shares@ $102.46 avg price
PCVX
Vaxcyte Inc
Recent Activity
Increased 17.83%
5.7%
$278.522M
4.793M shares@ $58.11 avg price
EWTX
Edgewise Therapeutics Inc
Recent Activity
Increased 12.6%
4.75%
$231.999M
7.365M shares@ $31.5 avg price
GMAB
Genmab A S -sp Adr
Recent Activity
Increased 13.19%
4.37%
$213.777M
7.968M shares@ $26.84 avg price
INSM
Insmed Inc
Recent Activity
New Position
4.2%
$205.134M
1.254M shares@ $163.53 avg price
TARS
Tarsus Pharmaceuticals Inc
Recent Activity
3.68%
$179.735M
2.562M shares@ $70.15 avg price
BLTE
Belite Bio Inc - Adr
Recent Activity
New Position
3.64%
$177.741M
1.115M shares@ $159.45 avg price
ERAS
Erasca Inc
Recent Activity
Decreased -26.6%
3.44%
$168.154M
10.393M shares@ $16.18 avg price

1-10 of 35